BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 18533764)

  • 1. Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
    McDougle CJ; Stigler KA; Erickson CA; Posey DJ
    J Clin Psychiatry; 2008; 69 Suppl 4():15-20. PubMed ID: 18533764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical antipsychotics for the treatment of disruptive behavior.
    Lohr WD; Honaker J
    Pediatr Ann; 2013 Feb; 42(2):72-7. PubMed ID: 23379410
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents.
    Findling RL
    J Clin Psychiatry; 2008; 69 Suppl 4():9-14. PubMed ID: 18533763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications.
    Wang PS; Schneeweiss S; Setoguchi S; Patrick A; Avorn J; Mogun H; Choudhry NK; Brookhart MA
    J Clin Psychopharmacol; 2007 Dec; 27(6):707-10. PubMed ID: 18004143
    [No Abstract]   [Full Text] [Related]  

  • 5. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008559. PubMed ID: 28791693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer?
    Dubois D
    Curr Opin Pediatr; 2005 Apr; 17(2):227-33. PubMed ID: 15800418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-generation antipsychotics cause weight gain in youths.
    Harv Ment Health Lett; 2010 Jan; 26(7):7. PubMed ID: 20217902
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder.
    Lorenz RA; Jackson CW; Saitz M
    Pharmacotherapy; 2010 Sep; 30(9):942-51. PubMed ID: 20795849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.
    Citrome L; Volavka J
    Postgrad Med; 2004 Oct; 116(4):49-51, 55-9, 63. PubMed ID: 15510593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical antipsychotics in the treatment of children and adolescents: clinical applications.
    Findling RL; McNamara NK
    J Clin Psychiatry; 2004; 65 Suppl 6():30-44. PubMed ID: 15104524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005.
    Pathak P; West D; Martin BC; Helm ME; Henderson C
    Psychiatr Serv; 2010 Feb; 61(2):123-9. PubMed ID: 20123816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A typical mood stabilizers: a "typical role for atypical antipsychotics.
    Malhi GS; Berk M; Bourin M; Ivanovski B; Dodd S; Lagopoulos J; Mitchell PB
    Acta Psychiatr Scand Suppl; 2005; (426):29-38. PubMed ID: 16104066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.
    Adler BA; Wink LK; Early M; Shaffer R; Minshawi N; McDougle CJ; Erickson CA
    Autism; 2015 Jan; 19(1):102-6. PubMed ID: 24571823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    Jing Y; Kim E; You M; Pikalov A; Tran QV
    J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of the atypical antipsychotics.
    Wooten J
    South Med J; 2007 Aug; 100(8):771-2. PubMed ID: 17713300
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of atypical antipsychotics in pediatric bipolar disorder.
    Chang KD
    J Clin Psychiatry; 2008; 69 Suppl 4():4-8. PubMed ID: 18533762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching antipsychotic medications: not enough, too often, or just right?
    Weiden PJ
    Am J Psychiatry; 2011 Sep; 168(9):882-4. PubMed ID: 21890800
    [No Abstract]   [Full Text] [Related]  

  • 18. The value of atypical antipsychotics in the treatment of schizophrenia.
    Jessen LM
    Manag Care; 2002 Jul; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization.
    Jin H; Shih PA; Golshan S; Mudaliar S; Henry R; Glorioso DK; Arndt S; Kraemer HC; Jeste DV
    J Clin Psychiatry; 2013 Jan; 74(1):10-8. PubMed ID: 23218100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model of anticholinergic activity of atypical antipsychotic medications.
    Chew ML; Mulsant BH; Pollock BG; Lehman ME; Greenspan A; Kirshner MA; Bies RR; Kapur S; Gharabawi G
    Schizophr Res; 2006 Dec; 88(1-3):63-72. PubMed ID: 16928430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.